LicianPro

IVBXF stock

Innovent Biologics Inc (IVBXF) short interest & short volume · 0.0% of float short

Innovent Biologics Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

IVBXF short interest rose 138.0% to 31K shares in the Oct 30, 2026 report (0.0% of float, 6.0 days to cover).

Short interest

Official, twice monthly · settled Oct 30, 2026

Shares short
31K
prior 13K
% of float
0.0%
float 1.61B
Days to cover
6.0
avg vol 5K
Change vs prior report
+138.0%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

IVBXF short interest by FINRA report (last 6) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 30, 202631K$306K+138.0%0.0%6.0$9.90
Oct 15, 202613K$163K-93.3%0.0%2.1$12.50
Sep 30, 2026194K$2.4M-81.2%0.0%129.2$12.53
Sep 15, 20261.0M$12.7M-1.9%0.1%252.4$12.34
Aug 31, 20261.1M$15.0M-11.7%0.1%417.4$14.27
Aug 14, 20261.2M$14.8M+15.0%0.1%321.3$12.37

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 30, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

No FINRA daily short volume on file for IVBXF yet.

Short squeeze score (model)

Price since settlement: +10.4%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

IVBXF's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · IVBXF overview

Healthcare peers with similar quant ratings

IVBXF among 542 rated Healthcare stocks (Lician quant rating, Nov 17, 2026). How the rating works

IVBXF short interest FAQ

What is IVBXF's short interest?

Innovent Biologics Inc (IVBXF) had 31K shares sold short and not yet covered in FINRA's Oct 30, 2026 settlement report, 0.0% of its 1.61B-share float.

How many days to cover does IVBXF have?

6.0 days: 31K shares short divided by an average daily volume of 5K for the Oct 30, 2026 period.

Is IVBXF short interest rising or falling?

IVBXF short interest rose (+138.0%) from 13K to 31K shares in the Oct 30, 2026 report.

Is IVBXF a short squeeze candidate?

Lician's squeeze watch scores IVBXF 38 out of 100 (low) from the Oct 30, 2026 report: short interest % of float 0/40, days to cover 15.1/25, change in short interest vs prior report 15/15, price change since settlement date 8.3/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What is IVBXF's market cap?

Innovent Biologics Inc (IVBXF) market cap is $17.76B on the latest cached fundamentals snapshot.

Where is IVBXF short volume listed?

Cached FINRA short volume for Innovent Biologics Inc (IVBXF) is listed at https://lician.com/short-interest/ivbxf.

Not investment advice. Figures as filed or reported, not a live feed.